Catastrophic anti-phospholipid syndrome associated with Escherichia coli O157 infection

Rheumatology

Volumn 48, Issue 9, 2009, Pages 1168-1169

  Shimizu, Masaki ^a   Yamazaki, Masahide ^b   Horisawa, Toru ^a   Seno, Akiko ^c   Ohta, Kazuhide ^d   Furuichi, Kengo ^e   Yachie, Akihiro ^a  

^a Department of Paediatrics ^*  (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Kanazawa Red Cross Hospital   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

^e KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CREATININE; D DIMER; FIBRINOGEN DEGRADATION PRODUCT; HEMOGLOBIN; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; PHOSPHATIDYLSERINE; PROTHROMBIN ANTIBODY; UREA; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ANURIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING TEST; BLOOD PRESSURE MEASUREMENT; BLOOD SMEAR; BLOODY DIARRHEA; CASE REPORT; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CHILD; CREATININE BLOOD LEVEL; DIALYSIS CATHETER; DISEASE ASSOCIATION; DISEASE COURSE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENZYME ACTIVITY; ERYTHROCYTE; ESCHERICHIA COLI INFECTION; FEMALE; FEVER; HEART RATE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOCYTE COUNT; LIVER FUNCTION TEST; PATIENT TRANSPORT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; REMISSION; RESUSCITATION; SCHOOL CHILD; TERMINAL DISEASE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREA BLOOD LEVEL; COLITIS; ESCHERICHIA COLI O157; VIROLOGY;

ANTIPHOSPHOLIPID SYNDROME; CHILD; COLITIS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; HUMANS;

EID: 70349784204     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep159     Document Type: Letter

References (9)

1. Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome. Where do we stand? Arthritis Rheum 2003;48:3320-7.
2. Cervera R, Piette J-C, Font J et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-27.
3. Asherson RA, Cervera R, de Groot PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-4.
4. Ardiles LG, Olavarría F, Elgueta M, Moya P, Mezzano S. Anticardiolipin antibodies in classic pediatric hemolytic-uremic syndrome: a possible pathogenic role. Nephron 1998;78:278-83.
5. Te Loo M, van der Velden T, Onland W, van den Heuvel L, Monnens L. Anticardiolipin antibodies in D+ hemolytic uremic syndrome. Pediatr Nephrol 2002;17:1042-6.
6. Asherson RA. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Autoimmun Rev 2006;6:76-80.
7. Asherson RA, Pierangeli S, Cervera R. Microangiopathic antiphospholipidassociated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes. J Rheumatol 2007;34:1793-5.
8. Amengual O, Atsumi T, Koike T. Antiprothrombin antibodies and the diagnosis of antiphospholipid syndrome. Clin Immunol 2004;112:144-9.
9. Atsumi T, Ieko M, Bertolaccini ML et al. Association of autoantibodies against the phosphatidylserine - prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000;43:1982-93.